Page last updated: 2024-09-03

gefitinib and licochalcone d

gefitinib has been researched along with licochalcone d in 1 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (licochalcone d)	Trials (licochalcone d)	Recent Studies (post-2010) (licochalcone d)
5,231	566	2,919	11	0	10

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chae, JI; Cho, SS; Kim, E; Kwak, AW; Lee, MH; Liu, K; Oh, HN; Shim, JH; Yoon, G	1

Other Studies

1 other study(ies) available for gefitinib and licochalcone d

Article	Year
Licochalcone D Induces ROS-Dependent Apoptosis in Gefitinib-Sensitive or Resistant Lung Cancer Cells by Targeting EGFR and MET. Biomolecules, 2020, 02-13, Volume: 10, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chalcones; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung; Lung Neoplasms; Membrane Potential, Mitochondrial; Proto-Oncogene Proteins c-met; Reactive Oxygen Species; Signal Transduction	2020

Article

Year

Licochalcone D Induces ROS-Dependent Apoptosis in Gefitinib-Sensitive or Resistant Lung Cancer Cells by Targeting EGFR and MET.

Biomolecules, 2020, 02-13, Volume: 10, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chalcones; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung; Lung Neoplasms; Membrane Potential, Mitochondrial; Proto-Oncogene Proteins c-met; Reactive Oxygen Species; Signal Transduction

2020